• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Medivir`s Fostrox + Lenvima Shows Promise In Liver Cancer

    PR NEWSWIRE

    Fostrox + Lenvima® holds promise of greatly improved outcomes

    PR NEWSWIRE

    Medivir Selects CRO For Phase 2b HCC Study With Fostrox + Lenvima

    PR NEWSWIRE

    Medivir to Present Fostrox + Lenvima Data in HCC at ESMO GI

    PR NEWSWIRE

    Medivir presents data on additive activity of fostrox with Lenvima or sorafenib

    PR NEWSWIRE

    Medivir reports promising interim data

    PR NEWSWIRE

    Promising tumor control for fostrox in combination with Lenvima in ongoing phase 2a study in HCC, 15th patient included

    PR NEWSWIRE

    China approves Medivir’s patent application for Fostrox

    PHARMACEUTICAL TECHNOLOGY

    Medivir to present data on efficacy of fostrox in combination with anti-PD1

    PR NEWSWIRE

    First patient dosed in Ph 2a part of Medivir`s study with fostrox with Lenvima

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.